Market Indices
Sector Heatmap
PGEN — Precigen, Inc. Common Stock
NasdaqPrecigen, Inc. Common Stock
- O
- 7.38
- H
- 7.75
- L
- 7.35
- V
- 4.14M
PGEN — Latest News & Headlines
20 StoriesPGEN Stock Up More Than 50% in 3 Months: Here's What You Should Know - Yahoo Finance
PGEN Stock Up More Than 50% in 3 Months: Here's What You Should Know Yahoo Finance
Why Did Precigen (PGEN) Stock Climb After Its Latest Update? - Simply Wall Street
Why Did Precigen (PGEN) Stock Climb After Its Latest Update? Simply Wall Street
$PGEN stock is down 11% today. Here's what we see in our data. - Quiver Quantitative
$PGEN stock is down 11% today. Here's what we see in our data. Quiver Quantitative
PGEN vs. IRWD: Which Biotech Stock Offers Better Growth Potential? - The Globe and Mail
PGEN vs. IRWD: Which Biotech Stock Offers Better Growth Potential? The Globe and Mail
Precigen (PGEN) Soars 6.3%: Is Further Upside Left in the Stock? - Yahoo Finance
Precigen (PGEN) Soars 6.3%: Is Further Upside Left in the Stock? Yahoo Finance
Precigen, Inc. (NASDAQ:PGEN) About To Shift From Loss To Profit - Moomoo
Precigen, Inc. (NASDAQ:PGEN) About To Shift From Loss To Profit Moomoo
Precigen: FDA’s Platform Technology Designation And Institutional Crossover Effect (PGEN) - Seeking Alpha
Precigen: FDA’s Platform Technology Designation And Institutional Crossover Effect (PGEN) Seeking Alpha
ACAD Stock Down 13% as Phase II Alzheimer's Study Misses Primary Goal - TradingView
ACAD Stock Down 13% as Phase II Alzheimer's Study Misses Primary Goal TradingView
Is Precigen (PGEN) Above Fair Value After The FDA Platform Nod? - Simply Wall Street
Is Precigen (PGEN) Above Fair Value After The FDA Platform Nod? Simply Wall Street
Precigen (PGEN) Gains FDA Platform Backing, Is The Stock Still Cheap? - Yahoo Finance
Precigen (PGEN) Gains FDA Platform Backing, Is The Stock Still Cheap? Yahoo Finance
UTHR Prevails in LQDA's Yutrepia Patent Dispute, Stock Up Nearly 13% - TradingView
UTHR Prevails in LQDA's Yutrepia Patent Dispute, Stock Up Nearly 13% TradingView
Precigen (PGEN) Gains FDA Platform Backing As Its Valuation Story Gets Harder To Ignore - Simply Wall Street
Precigen (PGEN) Gains FDA Platform Backing As Its Valuation Story Gets Harder To Ignore Simply Wall Street
Learn Why The Bull Case For Precigen (PGEN) Could Change Following FDA Platform Designation - Simply Wall Street
Learn Why The Bull Case For Precigen (PGEN) Could Change Following FDA Platform Designation Simply Wall Street
MRNA, PGEN Stocks Hit Multi-Year Highs – What’s Driving The Momentum Today? - Yahoo Finance
MRNA, PGEN Stocks Hit Multi-Year Highs – What’s Driving The Momentum Today? Yahoo Finance
Precigen (PGEN) Gets FDA Recognition. Can it Cut the Cost of Developing New Drugs? - Yahoo Finance
Precigen (PGEN) Gets FDA Recognition. Can it Cut the Cost of Developing New Drugs? Yahoo Finance
PGEN Oct 2026 10.000 call (PGEN261016C00010000) Stock Price, News, Quote & History - Yahoo! Finance Canada
PGEN Oct 2026 10.000 call (PGEN261016C00010000) Stock Price, News, Quote & History Yahoo! Finance Canada
Inovio Pharmaceuticals, Inc. (INO) Stock Price, News, Quote & History - Yahoo! Finance Canada
Inovio Pharmaceuticals, Inc. (INO) Stock Price, News, Quote & History Yahoo! Finance Canada
KOD Stock Soars 178% on Positive Wet AMD Data as BLA Filing Nears - TradingView
KOD Stock Soars 178% on Positive Wet AMD Data as BLA Filing Nears TradingView
Inovio Pharmaceuticals, Inc. (INO) stock price, news, quote and history - Yahoo Finance UK
Inovio Pharmaceuticals, Inc. (INO) stock price, news, quote and history Yahoo Finance UK
Merck's Remigromig Meets Main Goal in Diabetic Macular Edema Study - TradingView
Merck's Remigromig Meets Main Goal in Diabetic Macular Edema Study TradingView